FIELD: medicine.
SUBSTANCE: method involves carrying out biochemical blood examination to determine IgG and IgA class Helicobacter pylori antibodies titer. The titer being equal to or greater than 1:200, clinical course of complicated stomach- or duodenal ulcer associated with helicobacter pylori is to be predicted.
EFFECT: high accuracy of prognosis.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING GASTRIC AND DUODENAL PEPTIC ULCER CASES | 2003 |
|
RU2241228C1 |
METHOD FOR PREDICTING THE FLOW OF GASTRIC AND DUODENAL ULCEROUS DISEASE | 2003 |
|
RU2246731C1 |
METHOD FOR DETECTING EFFICIENCY OF APITHERAPY IN CASE OF ULCEROUS DUODENAL DISEASE | 2003 |
|
RU2247568C1 |
METHOD FOR PREDICTING CLINICAL COURSE OF NONHEALING PEPTIC STOMACH AND DUODENAL ULCER | 2003 |
|
RU2255661C1 |
METHOD FOR TREATMENT OF STOMACH AND DUODENUM ULCEROUS DISEASE | 2003 |
|
RU2240119C1 |
METHOD FOR TREATMENT OF HELICOBACTER-ASSOCIATED STOMACH AND DUODENUM INTESTINE ULCEROUS DISEASE | 2004 |
|
RU2278685C1 |
METHOD FOR DETECTING INDICATIONS FOR IMMUNOLOGICAL CORRECTION OF CROHN'S DISEASE AND INSPECIFIC ULCEROUS COLITIS | 2003 |
|
RU2258223C2 |
METHOD FOR PREDICTING PYLOROSTENOSIS DEVELOPMENT | 2005 |
|
RU2302004C1 |
METHOD OF EVALUATION OF REGENERATION OF GASTRIC ULCERS AND DUODENAL ULCERS | 2008 |
|
RU2397708C2 |
METHOD FOR ERADICATION OF HELICOBACTER PYLORI INFECTION IN STOMACH AND DUODENUM | 2004 |
|
RU2285534C2 |
Authors
Dates
2006-01-27—Published
2003-11-13—Filed